SION
Sionna Therapeutics, Inc. NASDAQ$40.45
Mkt Cap $1.8B
52w Low $11.77
82.7% of range
52w High $46.46
50d MA $38.15
200d MA $34.06
P/E (TTM)
-20.8x
EV/EBITDA
-18.0x
P/B
5.1x
Debt/Equity
0.0x
ROE
-24.5%
P/FCF
-24.7x
RSI (14)
—
ATR (14)
—
Beta
3.01
50d MA
$38.15
200d MA
$34.06
Avg Volume
356.8K
About
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | BMO | -0.54 | -0.46 | +14.7% | 33.92 | +0.0% | +0.5% | +1.9% | +1.9% | +5.9% | +10.6% | +21.8% | — |
| Nov 5, 2025 | BMO | -0.52 | -0.46 | +11.5% | 35.08 | -0.3% | -1.9% | -1.1% | +2.0% | +3.9% | +4.3% | +14.9% | — |
| Aug 11, 2025 | BMO | -0.68 | -0.41 | +39.7% | 20.03 | -0.7% | +4.8% | +4.4% | +4.4% | +3.9% | +6.8% | +17.2% | — |
| May 12, 2025 | BMO | -0.45 | -0.62 | -37.8% | 12.90 | -3.6% | -0.5% | -7.0% | +4.2% | +4.1% | +12.5% | +33.8% | — |
| Mar 20, 2025 | BMO | -0.57 | -3.38 | -493.0% | 13.88 | -1.2% | -1.4% | -12.8% | -6.8% | -13.3% | -13.7% | -18.6% | — |
| Nov 27, 2024 | BMO | — | -0.92 | — | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | Jones Trading | Maintains | Buy → Buy | — | $39.21 | $39.68 | +1.2% | +1.0% | -4.5% | -1.3% | -0.2% | — |
| Apr 27 | BTIG | Maintains | Buy → Buy | — | $38.11 | $38.02 | -0.2% | +2.9% | +3.9% | -1.8% | +1.5% | +2.7% |
| Mar 3 | Guggenheim | Maintains | Buy → Buy | — | $33.92 | $33.92 | +0.0% | +0.5% | +1.9% | +1.9% | +5.9% | +10.6% |
| Mar 2 | BTIG | Maintains | Buy → Buy | — | $36.54 | $32.89 | -10.0% | -7.2% | -6.7% | -5.4% | -5.4% | -1.7% |
| Jan 14 | BTIG | Maintains | Buy → Buy | — | $36.81 | $36.89 | +0.2% | +11.9% | +5.5% | +6.2% | +8.7% | +10.8% |
| Jan 7 | BTIG | Maintains | Buy → Buy | — | $37.22 | $38.14 | +2.5% | +16.1% | -1.7% | +5.5% | -2.4% | -1.1% |
| Dec 1 | RBC Capital | Downgrade | Sector Perform → Underperform | — | $43.57 | $40.76 | -6.4% | -10.6% | -10.5% | -5.5% | -6.2% | -7.5% |
Recent Filings
Data updated apr 27, 2026 1:21am
· Source: massive.com